A randomized phase 3 trial of interferon-a vs hydroxyurea in polycythemia vera and essential thrombocythemia. (2022)

First Author: Mascarenhas J

Attributed to: The Oxford Single Cell Biology Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021012743

PubMed Identifier: 35007321

Publication URI: http://europepmc.org/abstract/MED/35007321

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 19

ISSN: 0006-4971